TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
66.87
66.87
Intervallo Annuale
23.30
69.20
Variazione giornaliera
-3.13%
Variazione Mensile
+16.30%
Variazione di 6 mesi
+114.05%
Variazione Annuale
+133.73%
Chiusura Precedente
69.0 3
Open
66.8 7
Minimo
66.8 7
High
66.8 7
Volume
165
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Diagnostica e Ricerca
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-21.65
Rapporto prezzo/fatturato
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Notizie